000 | 03028cam a2200481Ki 4500 | ||
---|---|---|---|
001 | ocn889675352 | ||
003 | OCoLC | ||
005 | 20190328114808.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 140830s2013 enka ob 001 0 eng d | ||
040 |
_aEBLCP _beng _epn _cEBLCP _dOCLCO _dN$T _dGZM _dMYG _dUIU _dOCLCF _dOPELS _dOCLCQ _dU3W _dD6H |
||
020 |
_a9781908818287 _q(electronic bk.) |
||
020 |
_a190881828X _q(electronic bk.) |
||
020 |
_z9781907568213 _q(print) |
||
035 | _a(OCoLC)889675352 | ||
050 | 4 | _aRM301.25 | |
072 | 7 |
_aMED _x071000 _2bisacsh |
|
082 | 0 | 4 | _a615.19 |
100 | 1 | _aLai, Yurong. | |
245 | 1 | 0 |
_aTransporters in drug discovery and development : detailed concepts and best practice / _h[electronic resource] _cYurong Lai. |
260 |
_aOxford : _bElsevier Science, _c2013. |
||
300 |
_a1 online resource (xxiii, 734 pages) : _billustrations. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 | _aWoodhead Publishing Series in Biomedicine | |
504 | _aIncludes bibliographical references and index. | ||
588 | 0 | _aPrint version of record. | |
505 | 0 | _aMembrane transporters and the diseases corresponding to functional defects -- P-glycoprotein (P-gp/MDR1)/ABCB1 -- Multidrug resistanceassociated protein 2 (MRP2/ABCC2) -- Breast cancer resistance protein (BCRP)/ABCG2 -- The bile salt export pump (BSEP/ABCB11) -- Organic aniontransporting polypeptides (OATPs/SLCOs) -- Organic anion, organic cation and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs and MATEs) -- Drug transporters in drug discovery and development -- 9 Transporter study methodologies. | |
500 | _aWritten by a leading researcher in the field, Transporters in Drug Discovery and Development provides a comprehensive and practical guide to drug transporter families that are the most important for drug discovery and development. It covers: an overview of transporter families and organ distribution; clinical relevant drug-drug interaction; clinical relevant polymorphism; drug transporter related pharmacokinetic, pharmacodynamics and toxicity; in vitro/in vivo probes of drug transport studies; the practical methodologies of industrial transporter screening and translational aspect in drug discovery. | ||
650 | 0 | _aBiopharmaceutics. | |
650 | 0 | _aDrug development. | |
650 | 0 |
_aDrugs _xDesign. |
|
650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh |
|
650 | 7 |
_aBiopharmaceutics. _2fast _0(OCoLC)fst00832650 |
|
650 | 7 |
_aDrug development. _2fast _0(OCoLC)fst00898670 |
|
650 | 7 |
_aDrugs _xDesign. _2fast _0(OCoLC)fst00898790 |
|
655 | 4 | _aElectronic books. | |
776 | 0 | 8 |
_iPrint version: _aLai, Yurong. _tTransporters in Drug Discovery and Development : Detailed Concepts and Best Practice. _dBurlington : Elsevier Science, �2013 _z9781907568213 |
830 | 0 | _aWoodhead Publishing series in biomedicine. | |
856 | 4 | 0 |
_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9781907568213 |
999 |
_c246950 _d246950 |